A stepped wedge cluster randomised trial of a cognitive remediation intervention in alcohol and other drug (AOD) residential treatment services

• Published in: BMC psychiatry Vol. 19; no. 1; pp. 70 - 11
• Main Authors: Berry, Jamie, Jacomb, Isabella, Lunn, Jo, Sedwell, Antoinette, Shakeshaft, Anthony, Kelly, Peter J, Sarrami, Pooria, James, Megan, Russell, Skye, Nardo, Talia, Barker, Daniel, Holmes, Jennifer
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 13.02.2019; BioMed Central; BMC
• Subjects: Alcohol; Alcohol and drug; Analysis; Australia; Care and treatment; Clinical outcomes; Clinical trials; Cognition & reasoning; Cognitive ability; Cognitive rehabilitation; Cognitive remediation; Cognitive Remediation - methods; Cognitive therapy; Customer satisfaction; Economic analysis; Evidence-based medicine; Executive Function; Goal setting; Health care reform; Humans; Intervention; Male; Medical care quality; Mental disorders; Mental health; Mental health services; Patient Satisfaction; Psychiatry; Quality of Life; Quantitative psychology; Randomized Controlled Trials as Topic - methods; Rehabilitation; Residential Treatment - methods; Risk Factors; Study Protocol; Substance abuse; Substance abuse treatment; Substance-Related Disorders - psychology; Substance-Related Disorders - therapy; Traumatic brain injury; Treatment Outcome; Treatment retention; Young Adult; Australia; Alcohol and drug; Cognitive rehabilitation; Executive function; Treatment retention; Cognitive remediation; Goal setting
• ISSN: 1471-244X; 1471-244X
• DOI: 10.1186/s12888-019-2044-4

Executive functioning impairment is common in substance use disorder and is a major risk factor for poor treatment outcomes, including treatment drop-out and relapse. Cognitive remediation interventions seek to improve executive functioning and offer a promising approach to increase the efficacy of alcohol and other drug (AOD) treatments and improve long-term therapeutic outcomes. This protocol describes a study funded by the NSW Agency for Clinical Innovation that assesses the effectiveness of delivering a six-week group-based intervention of cognitive remediation in an ecologically valid sample of people attending residential AOD treatment services. We primarily aim to investigate whether cognitive remediation will be effective in improving executive functioning and treatment retention rates. We will also evaluate if cognitive remediation may reduce long-term AOD use and rates of health service utilisation, as well as improve personal goal attainment, quality of life, and client satisfaction with treatment. In addition, the study will involve an economic analysis of the cost of delivering cognitive remediation. The study uses a stepped wedge cluster randomised design, where randomisation will occur at the cluster level. Participants will be recruited from ten residential AOD treatment services provided by the non-government sector. The intervention will be delivered in 12 one-hour group-based sessions over a period of six weeks. All participants who are expected to receive treatment for the duration of the six-week intervention will be asked to participate in the study. The clusters of participants who are randomly assigned to the treatment condition will complete cognitive remediation in addition to treatment as usual (TAU). Primary and secondary outcome assessments will be conducted at pre-cognitive remediation/TAU phase, post-cognitive remediation/TAU phase, two-month follow-up, four-month follow-up, six-month follow-up, and eight-month follow-up intervals. This study will provide comprehensive data on the effect of delivering a cognitive remediation intervention within residential AOD treatment services. If shown to be effective, cognitive remediation may be incorporated as an adjunctive intervention in current treatment programs. Australian and New Zealand Clinical Trials Register (ANZCTR): ACTRN12618001190291 . Prospectively registered 17th July 2018.